"This is changing the way we practice prostate cancer." White House chief of staff Susie Wiles has breast cancer. She'll join ...
GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...
Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...
GentiBio, Inc., a clinical-stage biotechnology company pioneering engineered, antigen-specific regulatory T cell (EngTreg) therapies, today announced that the first participant has been dosed in ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...
The pseudomonal infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline ...
A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on ...
Researchers led by Mass General Brigham report that older adults who took a daily multivitamin for two years showed signs of slower biological aging. The effect was strongest among participants who ...
GlobalData on MSN
GEN secures BEBO Foundation approval for Phase II PD trial
The study will assess the effects of SUL-238 on high energy phosphates using 31P-MRS in PD patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results